Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2/3, double-blind, randomised, placebo-controlled trial. . Lancet Neurol 2025;24:500-511.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Safety and efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2/3, double-blind, randomised, placebo-controlled trial. Lancet Neurol 2025;24:500-511.
PMID: 40409314